Effect of Transcranial Direct Current Stimulation on Sensory Integration
Launched by MTI UNIVERSITY · Aug 13, 2020
Trial Information
Current as of August 31, 2025
Unknown status
Keywords
ClinConnect Summary
PURPOSE:
To determine the effect of Transcranial direct current stimulation on sensory integration and risk of falling in diabetic polyneuropathy.
BACKGROUND:
Diabetic polyneuropathy is the most prevalent chronic complication affecting 30% - 50% of diabetic patients. Diabetic polyneuropathy usually affect the peripheral, autonomic, and central nervous systems with several clinical symptoms .About 80% of the cases of DN manifest as distal symmetrical sensorimotor polyneuropathy which is responsible for cases of chronic pain; impaired sleep quality; increase of the falling risk associated ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1 - Patient will be diagnosed as having Diabetic Polyneuropathy (DPN) and all patients have type II diabetes.
- • 2-The age of the patients ranged from 35 to 55 years.
- • 3-Clinically all patients suffered from glove stock hyposthesia, numbness and burning sensation and mild distal moror weakness
- • 4-Patients have sensorymotor peripheral neuropathy according to neurophysiological study to detect sensory and motor conduction velocity to confirm diagnosis.
- Exclusion Criteria:
- • 1. History of diabetic ulcer and amputation .
- • 2. Osteoporosis.
- • 3. Fractures of lower limbs.
- • 4. Gross musculoskeletal problems eg:burn.
- • 5. Significant Scar tissue or calluses on the feet.
- • 6. Peripheral vascular diseases (PVD) or Microcirculation problems.
- • 7. Balance disturbance rather than diabetic peripheral neuropathy as ear problems, labrynthinitis, stroke or cerebellar problems.
- • 8. Visual disturbance.
- • 9. Autonomic neuropathy.
- • 10. Advanced Osteoarthritis of lower limbs.
- • 11. Nerve root compression (Radicuolopathy) affecting lower limbs.
- • 12. Patients with implanted devices for pain control such as deep brain
About Mti University
MTI University is a leading academic institution dedicated to advancing healthcare and medical research through innovative clinical trials. Committed to fostering collaboration between academic researchers and industry partners, MTI University focuses on developing cutting-edge therapies and technologies aimed at improving patient outcomes. With a robust infrastructure and a team of experienced professionals, the university prioritizes ethical standards and regulatory compliance in its research endeavors, ensuring the highest quality of care and safety for participants. As a sponsor, MTI University is dedicated to contributing valuable insights to the scientific community and enhancing the overall landscape of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials